Tony di Pietro
Directeur Financier/CFO chez CANN GROUP LIMITED
Postes actifs de Tony di Pietro
Sociétés | Poste | Début | Fin |
---|---|---|---|
CANN GROUP LIMITED | Directeur Financier/CFO | 08/04/2024 | - |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Corporate Officer/Principal | - | - |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - | - |
BARD1AG SA
BARD1AG SA Medical/Nursing ServicesHealth Services BARD1AG SA develops blood tests for the early detection of colorectal and lung cancer based on cancer-specific BARD1 isoforms. It offers screening and diagnosis services. The company was founded by Irmgard Irminger-Finger and Tony Walker in 2010 is headquartered in Geneva, Switzerland. | Directeur/Membre du Conseil | - | - |
Secrétaire Général | - | - |
Historique de carrière de Tony di Pietro
Anciens postes connus de Tony di Pietro
Sociétés | Poste | Début | Fin |
---|---|---|---|
GENETIC TECHNOLOGIES LIMITED | Directeur Financier/CFO | 28/11/2022 | 25/03/2024 |
Secrétaire Général | 28/11/2022 | 25/03/2024 | |
INOVIQ LTD | Directeur Financier/CFO | 28/07/2020 | 02/11/2022 |
Secrétaire Général | - | 02/11/2022 | |
ACRUX LIMITED | Directeur Financier/CFO | 16/08/2013 | 29/09/2014 |
Investor Relations Contact | 01/03/2004 | 01/11/2014 | |
Secrétaire Général | 16/08/2013 | 29/09/2014 | |
SIENNA CANCER DIAGNOSTICS LIMITED | Directeur/Membre du Conseil | 06/02/2020 | 28/07/2020 |
Directeur Financier/CFO | 01/11/2014 | - | |
Secrétaire Général | 25/02/2015 | - |
Formation de Tony di Pietro
Swinburne University of Technology | Undergraduate Degree |
Statistiques
Internationale
Australie | 9 |
Suisse | 2 |
Opérationnelle
Director of Finance/CFO | 5 |
Corporate Secretary | 5 |
Director/Board Member | 2 |
Sectorielle
Health Technology | 4 |
Commercial Services | 3 |
Health Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 4 |
---|---|
ACRUX LIMITED | Health Technology |
INOVIQ LTD | Health Services |
GENETIC TECHNOLOGIES LIMITED | Health Technology |
CANN GROUP LIMITED | Process Industries |
Entreprise privées | 4 |
---|---|
Sienna Cancer Diagnostics Ltd.
Sienna Cancer Diagnostics Ltd. BiotechnologyHealth Technology Sienna Cancer Diagnostics Ltd. operates as a medical technology company. It delivers sensitive, novel, robust and test for early detection of cancer, assessment of cancer treatments and assistance in drug development. The company was founded in 2002 and is headquartered in Scoresby, Australia. | Health Technology |
Governance Institute of Australia Ltd.
Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Commercial Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
BARD1AG SA
BARD1AG SA Medical/Nursing ServicesHealth Services BARD1AG SA develops blood tests for the early detection of colorectal and lung cancer based on cancer-specific BARD1 isoforms. It offers screening and diagnosis services. The company was founded by Irmgard Irminger-Finger and Tony Walker in 2010 is headquartered in Geneva, Switzerland. | Health Services |
- Bourse
- Insiders
- Tony di Pietro
- Expérience